Total Funding
39
59
Total FundingSeries A raised
Growth Score 39 in past quarter
0 pts
Heat Score 59 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
104988
ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technology.
- Egor Melnikov: CEO and Founder
- George Nikitin: Board Member, CTO
About the Company
ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technologies. The company is driven by a mission to save lives from cancer by giving people early diagnosis when cancer can be cured. Its genetic test is based on the analysis of free-circulating DNA in blood plasma and fluid biopsy technologies, enabling doctors
to do early diagnosis and treatment initiation for cancer.
The company was founded in 2013 and is headquartered in Moscow City.